Colin John Meyer - Feb 28, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: Chief Innovation Officer
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Feb 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/1/2023, 03:18 PM
Previous filing: Jan 4, 2023
Next filing: Mar 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$0	+15K	+19.86%	$0.00	90.5K	Feb 28, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Employee Stock Option (right-to-buy)	Award	$0	+30K		$0.00	30K	Feb 28, 2023	Class A common stock	30K	$27.32	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units granted with performance criteria (PSUs). On January 2, 2021, the reporting person was granted 15,000 PSUs. On February 28, 2023, based on the satisfaction of certain performance criteria, the PSUs vested as to 6,563 shares and is set to vest one quarter of 11,250 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.
F2	On January 3, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 13,125 shares and is set to vest 5,625 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.

Content

The shares represent Restricted Stock Units granted with performance criteria (PSUs). On January 2, 2021, the reporting person was granted 15,000 PSUs. On February 28, 2023, based on the satisfaction of certain performance criteria, the PSUs vested as to 6,563 shares and is set to vest one quarter of 11,250 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.

On January 3, 2022, the reporting person was granted an option to purchase 30,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 13,125 shares and is set to vest 5,625 shares on March 31, 2023; June 30, 2023, and September 30, 2023, subject to continued service through each vesting date.